AU5515299A - 9-dialkylamino purinone derivatives - Google Patents

9-dialkylamino purinone derivatives

Info

Publication number
AU5515299A
AU5515299A AU55152/99A AU5515299A AU5515299A AU 5515299 A AU5515299 A AU 5515299A AU 55152/99 A AU55152/99 A AU 55152/99A AU 5515299 A AU5515299 A AU 5515299A AU 5515299 A AU5515299 A AU 5515299A
Authority
AU
Australia
Prior art keywords
dialkylamino
purinone derivatives
purinone
derivatives
dialkylamino purinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU55152/99A
Inventor
Erwin Bischoff
Helmut Haning
Jorg Keldenich
Ulrich Niewohner
Ulrich Rosentreter
Thomas Schenke
Karl-Heinz Schlemmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU5515299A publication Critical patent/AU5515299A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
AU55152/99A 1998-08-24 1999-08-11 9-dialkylamino purinone derivatives Withdrawn AU5515299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998138300 DE19838300A1 (en) 1998-08-24 1998-08-24 9-dialkylaminopurinone derivatives
DE19838300 1998-08-24
PCT/EP1999/005908 WO2000011002A1 (en) 1998-08-24 1999-08-11 9-dialkylamino purinone derivatives

Publications (1)

Publication Number Publication Date
AU5515299A true AU5515299A (en) 2000-03-14

Family

ID=7878466

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55152/99A Withdrawn AU5515299A (en) 1998-08-24 1999-08-11 9-dialkylamino purinone derivatives

Country Status (3)

Country Link
AU (1) AU5515299A (en)
DE (1) DE19838300A1 (en)
WO (1) WO2000011002A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
EP1379520B2 (en) 2001-02-23 2014-04-09 Merck Sharp & Dohme Corp. N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
AU2002338334B8 (en) 2001-04-03 2008-09-18 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
JP2007515490A (en) * 2003-12-22 2007-06-14 アムジェン インコーポレーティッド Arylsulfonamide compounds and related uses
KR102590848B1 (en) 2016-12-28 2023-10-19 다트 뉴로사이언스, 엘엘씨 Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors
JP7254078B2 (en) 2017-11-27 2023-04-07 ダート・ニューロサイエンス・エルエルシー Substituted furanopyrimidine compounds as PDE1 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
DE19501480A1 (en) * 1995-01-19 1996-07-25 Bayer Ag 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one

Also Published As

Publication number Publication date
DE19838300A1 (en) 2000-03-02
WO2000011002A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU5759999A (en) Pyrimidone derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU5065999A (en) Naphthyridine derivatives
AU7813598A (en) Betulinol derivatives
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU5515299A (en) 9-dialkylamino purinone derivatives
AU3685097A (en) N-benzylazolium derivatives
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU6115798A (en) Saponarin derivatives
AU1562199A (en) Amino-benzothiazole derivatives
AU2640999A (en) 1-azaindolizine derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives
AU5239899A (en) Amidophosphate derivatives
AU2894099A (en) Phenanthrofuran derivatives
AU1691399A (en) 5-arylpyrrole derivatives
AU2123797A (en) 2-thioxotetrahydropyrimidin-4-one derivatives
AU9538898A (en) Pyrrolopyrrolone derivatives

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant